Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Transdermal Patch Market Report 2016

  • QYR778107
  • 96 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Transdermal Patch

Revenue, means the sales value of Transdermal Patch

This report studies sales (consumption) of Transdermal Patch in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Hisamitsu Pharmaceutical

Novartis

Johnson & Johnson

Teikoku Pharma

Mylan

Actavis

Mundipharma

Henan Lingrui Pharmaceutical

Changzhou Siyao

Rfl Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Fentanyl Transdermal Patch

Nicotine Transdermal Patch

Clonidine Transdermal Patch

Buprenorphine Transdermal Patch

Split by applications, this report focuses on sales, market share and growth rate of Transdermal Patch in each application, can be divided into

Relieve severe pain

Stop smoking cigarettes

Treat an overactive bladder

Others

Table of Contents

United States Transdermal Patch Market Report 2016

1 Transdermal Patch Overview

1.1 Product Overview and Scope of Transdermal Patch

1.2 Classification of Transdermal Patch

1.2.1 Fentanyl Transdermal Patch

1.2.2 Nicotine Transdermal Patch

1.2.3 Clonidine Transdermal Patch

1.2.4 Buprenorphine Transdermal Patch

1.3 Application of Transdermal Patch

1.3.1 Relieve severe pain

1.3.2 Stop smoking cigarettes

1.3.3 Treat an overactive bladder

1.3.4 Others

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Transdermal Patch (2011-2021)

1.4.1 United States Transdermal Patch Sales and Growth Rate (2011-2021)

1.4.2 United States Transdermal Patch Revenue and Growth Rate (2011-2021)

2 United States Transdermal Patch Competition by Manufacturers

2.1 United States Transdermal Patch Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Transdermal Patch Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Transdermal Patch Average Price by Manufactures (2015 and 2016)

2.4 Transdermal Patch Market Competitive Situation and Trends

2.4.1 Transdermal Patch Market Concentration Rate

2.4.2 Transdermal Patch Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Transdermal Patch Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Transdermal Patch Sales and Market Share by Type (2011-2016)

3.2 United States Transdermal Patch Revenue and Market Share by Type (2011-2016)

3.3 United States Transdermal Patch Price by Type (2011-2016)

3.4 United States Transdermal Patch Sales Growth Rate by Type (2011-2016)

4 United States Transdermal Patch Sales (Volume) by Application (2011-2016)

4.1 United States Transdermal Patch Sales and Market Share by Application (2011-2016)

4.2 United States Transdermal Patch Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Transdermal Patch Manufacturers Profiles/Analysis

5.1 Hisamitsu Pharmaceutical

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Transdermal Patch Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Novartis

5.2.2 Transdermal Patch Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Johnson & Johnson

5.3.2 Transdermal Patch Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Teikoku Pharma

5.4.2 Transdermal Patch Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Teikoku Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Mylan

5.5.2 Transdermal Patch Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Actavis

5.6.2 Transdermal Patch Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Actavis Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Mundipharma

5.7.2 Transdermal Patch Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Henan Lingrui Pharmaceutical

5.8.2 Transdermal Patch Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Henan Lingrui Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Changzhou Siyao

5.9.2 Transdermal Patch Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Changzhou Siyao Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Rfl Pharmaceutical

5.10.2 Transdermal Patch Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Rfl Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Transdermal Patch Manufacturing Cost Analysis

6.1 Transdermal Patch Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Transdermal Patch

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Transdermal Patch Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Transdermal Patch Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Transdermal Patch Market Forecast (2016-2021)

10.1 United States Transdermal Patch Sales, Revenue Forecast (2016-2021)

10.2 United States Transdermal Patch Sales Forecast by Type (2016-2021)

10.3 United States Transdermal Patch Sales Forecast by Application (2016-2021)

10.4 Transdermal Patch Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Transdermal Patch

Table Classification of Transdermal Patch

Figure United States Sales Market Share of Transdermal Patch by Type in 2015

Figure Fentanyl Transdermal Patch Picture

Figure Nicotine Transdermal Patch Picture

Figure Clonidine Transdermal Patch Picture

Figure Buprenorphine Transdermal Patch Picture

Table Application of Transdermal Patch

Figure United States Sales Market Share of Transdermal Patch by Application in 2015

Figure Relieve severe pain Examples

Figure Stop smoking cigarettes Examples

Figure Treat an overactive bladder Examples

Figure Others Examples

Figure United States Transdermal Patch Sales and Growth Rate (2011-2021)

Figure United States Transdermal Patch Revenue and Growth Rate (2011-2021)

Table United States Transdermal Patch Sales of Key Manufacturers (2015 and 2016)

Table United States Transdermal Patch Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Transdermal Patch Sales Share by Manufacturers

Figure 2016 Transdermal Patch Sales Share by Manufacturers

Table United States Transdermal Patch Revenue by Manufacturers (2015 and 2016)

Table United States Transdermal Patch Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Transdermal Patch Revenue Share by Manufacturers

Table 2016 United States Transdermal Patch Revenue Share by Manufacturers

Table United States Market Transdermal Patch Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Transdermal Patch Average Price of Key Manufacturers in 2015

Figure Transdermal Patch Market Share of Top 3 Manufacturers

Figure Transdermal Patch Market Share of Top 5 Manufacturers

Table United States Transdermal Patch Sales by Type (2011-2016)

Table United States Transdermal Patch Sales Share by Type (2011-2016)

Figure United States Transdermal Patch Sales Market Share by Type in 2015

Table United States Transdermal Patch Revenue and Market Share by Type (2011-2016)

Table United States Transdermal Patch Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Transdermal Patch by Type (2011-2016)

Table United States Transdermal Patch Price by Type (2011-2016)

Figure United States Transdermal Patch Sales Growth Rate by Type (2011-2016)

Table United States Transdermal Patch Sales by Application (2011-2016)

Table United States Transdermal Patch Sales Market Share by Application (2011-2016)

Figure United States Transdermal Patch Sales Market Share by Application in 2015

Table United States Transdermal Patch Sales Growth Rate by Application (2011-2016)

Figure United States Transdermal Patch Sales Growth Rate by Application (2011-2016)

Table Hisamitsu Pharmaceutical Basic Information List

Table Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Hisamitsu Pharmaceutical Transdermal Patch Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Transdermal Patch Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson Transdermal Patch Sales Market Share (2011-2016)

Table Teikoku Pharma Basic Information List

Table Teikoku Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teikoku Pharma Transdermal Patch Sales Market Share (2011-2016)

Table Mylan Basic Information List

Table Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mylan Transdermal Patch Sales Market Share (2011-2016)

Table Actavis Basic Information List

Table Actavis Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Table Actavis Transdermal Patch Sales Market Share (2011-2016)

Table Mundipharma Basic Information List

Table Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mundipharma Transdermal Patch Sales Market Share (2011-2016)

Table Henan Lingrui Pharmaceutical Basic Information List

Table Henan Lingrui Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Table Henan Lingrui Pharmaceutical Transdermal Patch Sales Market Share (2011-2016)

Table Changzhou Siyao Basic Information List

Table Changzhou Siyao Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Table Changzhou Siyao Transdermal Patch Sales Market Share (2011-2016)

Table Rfl Pharmaceutical Basic Information List

Table Rfl Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2011-2016)

Table Rfl Pharmaceutical Transdermal Patch Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Transdermal Patch

Figure Manufacturing Process Analysis of Transdermal Patch

Figure Transdermal Patch Industrial Chain Analysis

Table Raw Materials Sources of Transdermal Patch Major Manufacturers in 2015

Table Major Buyers of Transdermal Patch

Table Distributors/Traders List

Figure United States Transdermal Patch Production and Growth Rate Forecast (2016-2021)

Figure United States Transdermal Patch Revenue and Growth Rate Forecast (2016-2021)

Table United States Transdermal Patch Production Forecast by Type (2016-2021)

Table United States Transdermal Patch Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370